These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 25119037)

  • 1. Inappropriate p53 activation during development induces features of CHARGE syndrome.
    Van Nostrand JL; Brady CA; Jung H; Fuentes DR; Kozak MM; Johnson TM; Lin CY; Lin CJ; Swiderski DL; Vogel H; Bernstein JA; Attié-Bitach T; Chang CP; Wysocka J; Martin DM; Attardi LD
    Nature; 2014 Oct; 514(7521):228-32. PubMed ID: 25119037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chromatin remodeling protein CHD7, mutated in CHARGE syndrome, is necessary for proper craniofacial and tracheal development.
    Sperry ED; Hurd EA; Durham MA; Reamer EN; Stein AB; Martin DM
    Dev Dyn; 2014 Sep; 243(9):1055-66. PubMed ID: 24975120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of fbxl10/kdm2bb rescues chd7 morphant phenotype in a zebrafish model of CHARGE syndrome.
    Balow SA; Pierce LX; Zentner GE; Conrad PA; Davis S; Sabaawy HE; McDermott BM; Scacheri PC
    Dev Biol; 2013 Oct; 382(1):57-69. PubMed ID: 23920116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHD7 regulates cardiovascular development through ATP-dependent and -independent activities.
    Yan S; Thienthanasit R; Chen D; Engelen E; Brühl J; Crossman DK; Kesterson R; Wang Q; Bouazoune K; Jiao K
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28847-28858. PubMed ID: 33127760
    [No Abstract]   [Full Text] [Related]  

  • 5. Guilty as CHARGED: p53's expanding role in disease.
    Van Nostrand JL; Attardi LD
    Cell Cycle; 2014; 13(24):3798-807. PubMed ID: 25483057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHD7, the gene mutated in CHARGE syndrome, regulates genes involved in neural crest cell guidance.
    Schulz Y; Wehner P; Opitz L; Salinas-Riester G; Bongers EM; van Ravenswaaij-Arts CM; Wincent J; Schoumans J; Kohlhase J; Borchers A; Pauli S
    Hum Genet; 2014 Aug; 133(8):997-1009. PubMed ID: 24728844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation.
    Lalani SR; Safiullah AM; Fernbach SD; Harutyunyan KG; Thaller C; Peterson LE; McPherson JD; Gibbs RA; White LD; Hefner M; Davenport SL; Graham JM; Bacino CA; Glass NL; Towbin JA; Craigen WJ; Neish SR; Lin AE; Belmont JW
    Am J Hum Genet; 2006 Feb; 78(2):303-14. PubMed ID: 16400610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHD7 and retinoic acid signaling cooperate to regulate neural stem cell and inner ear development in mouse models of CHARGE syndrome.
    Micucci JA; Layman WS; Hurd EA; Sperry ED; Frank SF; Durham MA; Swiderski DL; Skidmore JM; Scacheri PC; Raphael Y; Martin DM
    Hum Mol Genet; 2014 Jan; 23(2):434-48. PubMed ID: 24026680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse Models for the Dissection of CHD7 Functions in Eye Development and the Molecular Basis for Ocular Defects in CHARGE Syndrome.
    Gage PJ; Hurd EA; Martin DM
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7923-30. PubMed ID: 26670829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHD7 represses the retinoic acid synthesis enzyme ALDH1A3 during inner ear development.
    Yao H; Hill SF; Skidmore JM; Sperry ED; Swiderski DL; Sanchez GJ; Bartels CF; Raphael Y; Scacheri PC; Iwase S; Martin DM
    JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Chd7 function in gene-trapped reporter mice is embryonic lethal and associated with severe defects in multiple developing tissues.
    Hurd EA; Capers PL; Blauwkamp MN; Adams ME; Raphael Y; Poucher HK; Martin DM
    Mamm Genome; 2007 Feb; 18(2):94-104. PubMed ID: 17334657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects in vestibular sensory epithelia and innervation in mice with loss of Chd7 function: implications for human CHARGE syndrome.
    Adams ME; Hurd EA; Beyer LA; Swiderski DL; Raphael Y; Martin DM
    J Comp Neurol; 2007 Oct; 504(5):519-32. PubMed ID: 17701983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defects in neural stem cell proliferation and olfaction in Chd7 deficient mice indicate a mechanism for hyposmia in human CHARGE syndrome.
    Layman WS; McEwen DP; Beyer LA; Lalani SR; Fernbach SD; Oh E; Swaroop A; Hegg CC; Raphael Y; Martens JR; Martin DM
    Hum Mol Genet; 2009 Jun; 18(11):1909-23. PubMed ID: 19279158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mutation in Chd7 causes misexpression of Bmp4 and developmental defects in telencephalic midline.
    Jiang X; Zhou Y; Xian L; Chen W; Wu H; Gao X
    Am J Pathol; 2012 Aug; 181(2):626-41. PubMed ID: 22658483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHARGE and Kabuki syndromes: a phenotypic and molecular link.
    Schulz Y; Freese L; Mänz J; Zoll B; Völter C; Brockmann K; Bögershausen N; Becker J; Wollnik B; Pauli S
    Hum Mol Genet; 2014 Aug; 23(16):4396-405. PubMed ID: 24705355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Semicircular Canal Hypoplasia in Patients With CHARGE Syndrome: 3C Syndrome.
    Wineland A; Menezes MD; Shimony JS; Shinawi MS; Hullar TE; Hirose K
    JAMA Otolaryngol Head Neck Surg; 2017 Feb; 143(2):168-177. PubMed ID: 27832265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotype and genotype analysis of a French cohort of 119 patients with CHARGE syndrome.
    Legendre M; Abadie V; Attié-Bitach T; Philip N; Busa T; Bonneau D; Colin E; Dollfus H; Lacombe D; Toutain A; Blesson S; Julia S; Martin-Coignard D; Geneviève D; Leheup B; Odent S; Jouk PS; Mercier S; Faivre L; Vincent-Delorme C; Francannet C; Naudion S; Mathieu-Dramard M; Delrue MA; Goldenberg A; Héron D; Parent P; Touraine R; Layet V; Sanlaville D; Quélin C; Moutton S; Fradin M; Jacquette A; Sigaudy S; Pinson L; Sarda P; Guerrot AM; Rossi M; Masurel-Paulet A; El Chehadeh S; Piguel X; Rodriguez-Ballesteros M; Ragot S; Lyonnet S; Bilan F; Gilbert-Dussardier B
    Am J Med Genet C Semin Med Genet; 2017 Dec; 175(4):417-430. PubMed ID: 29178447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and nonimmunologic phenotypic features.
    Jyonouchi S; McDonald-McGinn DM; Bale S; Zackai EH; Sullivan KE
    Pediatrics; 2009 May; 123(5):e871-7. PubMed ID: 19403480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHD7 mutations and CHARGE syndrome in semicircular canal dysplasia.
    Green GE; Huq FS; Emery SB; Mukherji SK; Martin DM
    Otol Neurotol; 2014 Sep; 35(8):1466-70. PubMed ID: 24979395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological and sensorimotor phenotypes in a zebrafish CHARGE syndrome model are domain-dependent.
    Hodorovich DR; Lindsley PM; Berry AA; Burton DF; Marsden KC
    Genes Brain Behav; 2023 Jun; 22(3):e12839. PubMed ID: 36717082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.